Introduction
Oxidatively modified low density lipoprotein (Ox-LDL) is generally accepted as a likely atherogenic lipoprotein in vivo (1). This is partly because Ox-LDL was demonstrated in human and rabbit atherosclerotic lesions (2, 3) and partly because various atherogenic properties of Ox-LDL have been demonstrated by in vitro experiments with vascular wall cells (4). Among these atherogenic properties, recent studies have shed light on the cytotoxic effect of Ox-LDL (5), because Ox-LDL-induced vascular cell death may enhance atherosclerotic lesion progression (6). In the current review, we focus on the cytotoxic effect of Ox-LDL on macrophages and their potential link to the progression of atherosclerosis.
Formation of Early Atherosclerotic Lesions
The appearance of lipid-laden macrophage-derived foam cells is a typical characteristic of the early stage of atherosclerotic lesions (7). Fig. 1 shows a widely accepted mechanism for the formation of macrophage foam cells in vivo (1). Circulating monocytes adhere to vascular endothelial cells, transmigrate into subendothelial space, and differentiate into macrophages which express scavenger receptors. LDL is oxidatively modified by arterial cells such as vascular endothelial cells, smooth muscle cells and macrophages, and eventually acquires a ligand activity for scavenger receptors (1). Ox-LDL is taken up by macrophages through the scavenger receptor pathway (1, 8) followed by delivery through endosomes to lysosomes (9). In the lysosomes, the protein moiety of modified LDLs is subjected to proteolytic hydrolysis, whereas the cholesterol moiety, mainly CE, is hydrolyzed to free cholesterol and fatty acids by acidic cholesteryl ester hydrolase (ACEH). Free cholesterol is then transported to plasma membrane (10) and is further delivered to the endoplasmic reticulum, where it is reesterified to CE by acyl-coenzyme A : cholesterol acyltransferase (ACAT) (11). Cellular CE undergoes continual hydrolysis to free cholesterol by neutral cholesterol ester hydrolase (NCEH) and subsequent re-esterification to CE by ACAT. This metabolic cycle is known as the cholesteryl ester cycle (CE cycle) (12, 13). Since macrophage foam cells are known to secrete various cytokines which trigger off further progression of atherosclerosis, formation of macrophage foam cells by the above mechanisms is regarded as a critical event in the lesion progression (7).
Formation of Advanced Atherosclerotic Lesions
In contrast to the early atherosclerotic lesions, atherosclerotic plaques, more advanced lesions, are characterized by the presence of acellular lipid-rich cores (lipid cores) composed of extracellular lipid deposits and cell debris (6, 7, 14). Extracellular lipids might partly derive from intracellular lipids released from dying or dead cells and might partly derive from plasma lipoproteins which was not taken up by cells because cells had been dead in the plaques. Therefore, cell death in atherosclerotic lesions is a key event for advanced lesion progression (6). Lipid cores are also called 'necrotic cores' due to the presence of dead cells. Among the various cells in vascular walls, immunohistochemical studies suggest that the major cell type dying in human atherosclerotic plaques is macrophages (15).
The atherogenic effects of Ox-LDL on macrophages include intracellular CE accumulation (1), chemotactic activity for monocytes (16), enhancement of monocyte adhesion to endothelial cells (17), initiation of monocyte differentiation into macrophages (18), and inhibition of tissue macrophage migration (19) . Recent studies have also demonstrated macrophage cell death induced by Ox-LDL (20), which is a novel aspect of Ox-LDL atherogenicity. Taken together, elucidation of the mechanism for macrophage cell death by Ox-LDL may provide new mechanistic insights into the development of advanced atherosclerotic lesions.
Cytotoxic Effect of Ox-LDL on Vascular Cells
Although the mechanism of cell death in atherosclerotic lesions in vivo is still unclear, in vitro experiments have proposed that Ox-LDL is a possible candidate that induces cell death (5). As shown in Table 1 (Table 1) . These studies emphasized that apoptosis is a major mechanism of Ox-LDL-induced macrophage cell death.
Reid et a/. (24) showed that exposure of P388D1 murine macrophage-like cells to Ox-LDL led to DNA fragmentation which is often used as a biochemical marker of apoptosis.
Using the same cell line, Harada et al. (25) showed that 7-ketocholesterol or 25-hydroxycholesterol induced apoptosis partly through a CPP32-activated and BcI-2-inhibitable pathway . Yuan et al. (26) suggested that the apoptosis induced by Ox-LDL is due to lysosomal damage in J774 macrophages. Recently, Kinscherf et al. (27) showed that manganese superoxide dismutase and p53 play essential roles in the Ox-LDL-induced apoptotic cell death of human monocyte-derived macrophages. Since macrophage apoptosis is observed in lipid cores of the human atherosclerotic lesions (14), Ox-LDL-induced macrophage apoptosis is a likely mechanism for macrophage cell death in the atherosclerotic lesions . However, despite our electron microscopic observations of J774 cells, we were unable to detect typical morphological features of apoptosis such as condensation of nuclear chromatin, the compact cytoplasmic organelles, and the blebbing of cell surfaces.
Thus, Ox-LDL seems to lead macrophages to "necrosis" as well as "apoptosis ."
One thing worth mention in this review is that the cytotoxicity of oxidized LDL in vitro is altered by the presence of serum components in the medium. In general, serum proteins reduces Ox-LDL cytotoxicity in cell culture. Lipoproteins in serum could adsorb cytotoxic polar lipids in Ox-LDL. Some serum proteins may behave as anti-oxidants.
Moreover, serum contains growth factors which rescue cell viability. As shown in Table 1 , some experiments were conducted under conditions too harsh to cells (e.g.. in serum-free medium). Since the concen- trations of serum components in atherosclerotic plaque cores are unclear, careful interpretations of these in vitro experiments are needed.
A Somatic Cell Genetic Approach to Ox-LDL-Induced
Macrophage Cell Death
Isolation of macrophage-like cell mutants resistant to the cytotoxicity of Ox-LDL In order to obtain molecular insights into the mechanisms involved in macrophage cell death by Ox-LDL, we made a macrophage cell genetic approach (28). Murine macrophage-like J774 cells were mutagenized with ethylmethane sulfonate and exposed to a lethal concentration of Ox-LDL (0.1 mg/ml). Then, resistant clones were selected.
One mutant form, named J021b cells, was characterized by molecular and cell biological methods. When assessed by MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) assay, cell viability of J774 cells was decreased almost to a basal level by 7-day incubation with 0.1 mg/ml of Ox-LDL, indicating that J774 cells were sensitive to the cytotoxic effect of Ox-LDL ( Fig. 2B) . At the same concentration, however, Ox-LDL had no effect at all on the cell viability of J021b cells, indicating resistance of J021b cells to the cytotoxic effect of Ox-LDL ( Fig. 2A) . Acetyl-LDL exhibited no cytotoxic effect on J021b cells or J774 cells ( Fig. 2A and B) . Rather, it showed a weak stimulating effect on the cell viability. The viability of these cells was not influenced by unmodified LDL, suggesting that the cytotoxic effect of Ox-LDL on J774 cells was selective among these LDL preparations.
A B
Ctotoxic effects of 7-ketocholesterol, t-butyl hydroperoxide and Iysophosphatidylcholine on J021b Cells The potential cytotoxic compounds of Ox-LDL include oxysterols (23, 29-31), lipid hydroperoxides (32-34) and lysophosphatidylcholines (35). Since we first hypothesized that an enzyme(s) involved in detoxification of the above compounds is overexpressed in J021b cells, we examined the effects of these compounds on the cell viability of J021b cells. As representatives of the three groups of the above cytotoxins, 7-ketocholesterol, tertiary-butyl (t-butyl) hydroperoxide and palmitoyl-lysophosphatidylcholine were tested (Fig. 3) . However, J021b cells were apparently as sensitive as the parent cells to these compounds (28). Next we examined the combined effects of these compounds on J021b cells. Again, there was no difference in the sensitivity between J021b and parent J774 cells. It is therefore unlikely that the enzymes involved in detoxification of certain cytotoxic compounds of Ox-LDL are overexpressed in J021b cells.
Cellular interaction of Ox-LDL with J021b cells
To elucidate the cellular metabolism of Ox-LDL in macrophages, the interaction of Ox-LDL with J021b cells (Fig. 4) (45), endocytic uptake of Ox-LDL by peritoneal macrophages from MSRAl/All-knockout mice was decreased only by 30% compared to that with their wild-type macrophages, indicating endocytic uptake of Ox-LDL mainly depends on receptors other than MSR-Al/All. However, our previous studies clearly showed that the cell-association of Ox-LDL by MSR-Al/All-knockout macrophages was reduced by >50-70% compared to wild-type (46, 47) . This difference in contribution of MAR-Al/All to cellular uptake of Ox-LDL might be derived from differences in ligand preparations and/or culture conditions. However, all these reports suggest that MSR-Al/All is one of the major receptors for Ox-LDL in murine macrophages.
mRNA expression of MSR-Al/All in J021b cells
If MSR-Al/All plays a major role in the endocytic uptake of Ox-LDL, reduction in endocytic degradation of Ox-LDL in JO21b cells (Fig. 4) suggests a possible reduction in MSR-Al/All activity in these cells. Northern blot analysis was performed to examine MSR-Al/All expression at an mRNA level. The expression level of mRNA for both MSR-Al and MSR-All was lower by 70% in JO21b cells than in J774 cells (28), suggesting that resistance to Ox-LDL cytotoxicity, the characteristic phenotype of JO21b cells, has a functional link to the reduced expression of MSR-Al/All and a concomitant decrease in uptake of Ox-LDL.
Cytotoxic Effect of Ox-LDL on Macrophages from MSRAl/All-Knockout Mice
In order to elucidate the correlation of reduced MSRAl/All activity to reduced sensitivity to the cytotoxic effect of Ox-LDL, we compared the sensitivity of peritoneal macrophages obtained from MSR-Al/All-knockout mice (47) with that of their wild-type littermates.
As shown in Fig. 5 , incubation with 0.2 mg/ml of Ox-LDL for 48 h caused total cell death of both wild-type and MSR-Al/ All-knockout macrophages. However, when incubated with 0.1 mg/ml of Ox-LDL, wild-type macrophages showed a 36.9% decrease in cell viability whereas knockout macrophages showed no change in cell viability (Fig.  5) . These results clearly indicate that peritoneal macrophages from MSR-Al/All-knockout mice are more resistant to the cytotoxic effect of Ox-LDL than those from wild-type mice, suggesting that MSR-Al/All plays an enhancing role in the cytotoxic effect of Ox-LDL toward macrophages.
Ox-LDL-Induced Macrophage Cell Death vs. Ox-LDLInduced Macrophage Growth
Proliferation of smooth muscle cells has been so far regarded as a critical step in the development of atherosclerosis (7). However, morphological studies have also demonstrated that macrophages or macrophage-derived foam cells proliferate in situ in atherosclerotic lesions (48) (49) (50) . Although the focus of this review is Ox-LDL-induced macrophage cell death, we reported previously that Ox-LDL also induces macrophage growth in mouse (51), human (52) and rat (53). In this process, endocytic uptake by MSR-Al/All of lysophosphatidylcholine of Ox-LDL plays an important role in the mitogenic effect of Ox-LDL (46, 54, 55) . It is interesting to note that Ox-LDLinduced macrophage growth shares a common mechanism with Ox-LDL-induced macrophage cell death, since both phenomena are enhanced by MSR-Al/All-mediated endocytic uptake of Ox-LDL.
Conclusions Fig. 6 shows our conclusions.
The potential cytotoxic compounds of Ox-LDL such as oxysterols, lipid hydroperoxides and lysophosphatidylcholines can be transferred to macrophages by at least two independent pathways. One is non-specific transfer of these toxic lipids to the plasma membrane by lipid exchange reaction.
The other is receptor-mediated endocytic uptake of Ox-LDL through MSR-Al/All.
Both pathways lead macrophages to necrotic and/or apoptotic death. Our recent study using macrophage cell genetics suggested that Ox-LDL-induced necrotic death of macrophages is enhanced by MSR-Al/All-mediated endocytic uptake of Ox-LDL (28). Recently, Nagy et al. (56) have shown that lysosomal degradation of Ox-LDL leads to the release of oxidized linoleic acids such as 9-hydroxyoctadecadienoic acid (9-HODE) and 13-hydroxyoctadecadienoic acid (13-HODE) through hydrolysis of oxidized cholesteryl linoleate. These oxidized fatty acids behave as the ligands for peroxisome proliferator activated receptor y (PPARy) and increase CD36 expression in human monocytes and THP-1 cells. The key finding of this report is that bioactive lipids are released from Ox-LDL through receptor-mediated endocytosis followed by lysosomal processing.
Thus, it is interesting to hypothesize that cytotoxic lipids in Ox-LDL are released through intracellular processing of Ox-LDL, increasing Ox-LDL cytotoxicity.
Finally, in vitro experiments using Ox-LDL often lead us to paradoxical conclusions on the atherogenicity of Ox-LDL (57). As we mentioned above, Ox-LDL is able to induce macrophage proliferation (for review, see 55) as well as macrophage cell death (28). Moreover, lyso-PC, a major phospholipid in Ox-LDL, behaves as a cytotoxic compound (Hakamata et al., 1998) but also behaves as a mitogenic factor for macrophages (46, 54) . It is unknown how Ox-LDL shows such paradoxical effects.
This might be due, in part, to the differences in the cell types, culture conditions, concentrations of Ox-LDL, and/or physicochemical properties of each Ox-LDL preparation. The potential cytotoxic compounds of Ox-LDL such as oxysterols, lipid hydroperoxides and lysophosphatidylcholines can be transferred to macrophages by at least two independent pathways. One pathway is receptor-mediated endocytic uptake of Ox-LDL through MSR-Al/All.
Lysosomal delivery and processing of Ox-LDL produce several bioactive compounds which may enhance expression of apoptosis-related genes, leading macrophages to apoptosis. Macrophage necrosis is possibly enhanced by the MSR-Al/All-mediated endocytic uptake of the toxic compound of Ox-LDL. The other pathway is non-specific transfer of these toxic lipids to the plasma membrane by lipid exchange reaction.
These toxic lipids or their unknown metabolites promote expression of several genes involved in apoptosis, which eventually leads macrophages to apoptotic cell death.
At the same time, these toxic lipids may cause necrotic cell death of macrophages.
studies are needed to address this issue. 
